Eminent speaker, Dr. Amit Kumar, Pharmacopoeial Scientist in Indian Pharmacopoeia Commission, Ghaziabad, delivered a guest lecture on Phytopharmaceutical Drugs and its Monograph in Indian Pharmacopoeia as an activity of PEPSC (Pharmacopoeial Education and Patient Safety cell) on 25th November 2022 during National Pharmacy week 2022 celebration at Sanskar College of Pharmacy, Ghaziabad. He shared that Phytopharmaceutical ingredient (PPI) monographs has been introduced in IP 2022 for the first time in Indian Pharmacopoeia. It may or may not strictly meet the requirements of definition of phytopharmaceutical drugs which are essentially herbal medicine extracted from plants. These are mixture of different compounds but have a biological origin from a plant. He said inclusion criteria of phytopharmaceutical drug monographs in IP differ from herbal drug monographs. To include a PPI monograph in Indian Pharmacopoeia (IP), an herbal drug fraction needs to be characterized minimum of its four bio/analytical marker compounds. Out of four markers, one analytical marker should have biological / therapeutic value. As a standard setting authority, the IPC ensures four analytical markers should be present in a phytopharmaceutical ingredient which is used for development for a botanical drug. The lecture was very well received by the B.Pharm and M.Pharm students. The information and practical insight in his deliberation will be useful for the students throughout their career.